You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 166 No. 15, Aug 14/28, 2006 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (147)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Men's Health
 •Men's Health, Other
 •Neurology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Low Serum Testosterone and Mortality in Male Veterans

Molly M. Shores, MD; Alvin M. Matsumoto, MD; Kevin L. Sloan, MD; Daniel R. Kivlahan, PhD

Arch Intern Med. 2006;166:1660-1665.

Background  Low serum testosterone is a common condition in aging associated with decreased muscle mass and insulin resistance. This study evaluated whether low testosterone levels are a risk factor for mortality in male veterans.

Methods  We used a clinical database to identify men older than 40 years with repeated testosterone levels obtained from October 1, 1994, to December 31, 1999, and without diagnosed prostate cancer. A low testosterone level was a total testosterone level of less than 250 ng/dL (<8.7 nmol/L) or a free testosterone level of less than 0.75 ng/dL (<0.03 nmol/L). Men were classified as having a low testosterone level (166 [19.3%]), an equivocal testosterone level (equal number of low and normal levels) (240 [28.0%]), or a normal testosterone level (452 [52.7%]). The risk for all-cause mortality was estimated using Cox proportional hazards regression models, adjusting for demographic and clinical covariates over a follow-up of up to 8 years.

Results  Mortality in men with normal testosterone levels was 20.1% (95% confidence interval [CI], 16.2%-24.1%) vs 24.6% (95% CI, 19.2%-30.0%) in men with equivocal testosterone levels and 34.9% (95% CI, 28.5%-41.4%) in men with low testosterone levels. After adjusting for age, medical morbidity, and other clinical covariates, low testosterone levels continued to be associated with increased mortality (hazard ratio, 1.88; 95% CI, 1.34-2.63; P<.001) while equivocal testosterone levels were not significantly different from normal testosterone levels (hazard ratio, 1.38; 95% CI, 0.99%-1.92%; P=.06). In a sensitivity analysis, men who died within the first year (50 [5.8%]) were excluded to minimize the effect of acute illness, and low testosterone levels continued to be associated with elevated mortality.

Conclusions  Low testosterone levels were associated with increased mortality in male veterans. Further prospective studies are needed to examine the association between low testosterone levels and mortality.


Author Affiliations: Geriatric Research, Education, and Clinical Center (Drs Shores and Matsumoto) and Center of Excellence in Substance Abuse Treatment and Education (Drs Sloan and Kivlahan), VA Puget Sound Health Care System, Seattle, Wash, and Departments of Psychiatry and Behavioral Sciences (Drs Shores, Sloan, and Kivlahan) and Medicine (Dr Matsumoto), University of Washington, Seattle.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low Free Testosterone Predicts Mortality from Cardiovascular Disease But Not Other Causes: The Health in Men Study
Hyde et al.
J. Clin. Endocrinol. Metab. 2012;97:179-189.
ABSTRACT | FULL TEXT  

Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
Corona et al.
Eur J Endocrinol 2011;165:687-701.
ABSTRACT | FULL TEXT  

Sex hormones and cause-specific mortality in the male veterans: the Vietnam Experience Study
Phillips et al.
QJM 2011;0:hcr204v1-hcr204.
ABSTRACT | FULL TEXT  

Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
Araujo et al.
J. Clin. Endocrinol. Metab. 2011;96:3007-3019.
ABSTRACT | FULL TEXT  

Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity
Dandona and Dhindsa
J. Clin. Endocrinol. Metab. 2011;96:2643-2651.
ABSTRACT | FULL TEXT  

Low serum testosterone, arterial stiffness and mortality in male haemodialysis patients
Kyriazis et al.
Nephrol Dial Transplant 2011;26:2971-2977.
ABSTRACT | FULL TEXT  

Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes
Wang et al.
Diabetes Care 2011;34:1669-1675.
FULL TEXT  

Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis
Ruige et al.
Heart 2011;97:870-875.
ABSTRACT | FULL TEXT  

Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography
Wehr et al.
Eur J Heart Fail 2011;13:482-488.
ABSTRACT | FULL TEXT  

Androgen stimulates endothelial cell proliferation via an androgen receptor/VEGF/cyclin A-mediated mechanism
Cai et al.
Am. J. Physiol. Heart Circ. Physiol. 2011;300:H1210-H1221.
ABSTRACT | FULL TEXT  

Association Between Serum Testosterone and Sex Hormone-Binding Globulin and Exercise Capacity in Men: Results of the Study of Health in Pomerania (SHIP)
Koch et al.
J Androl 2011;32:135-143.
ABSTRACT | FULL TEXT  

Review: Testosterone and the metabolic syndrome
Muraleedharan and Jones
Therapeutic Advances in Endocrinology and Metabolism 2010;1:207-223.
ABSTRACT  

Low serum testosterone and increased mortality in men with coronary heart disease
Malkin et al.
Heart 2010;96:1821-1825.
ABSTRACT | FULL TEXT  

Testosterone levels and cardiovascular disease
Ma and Tong
Heart 2010;96:1787-1788.
FULL TEXT  

Testosterone deficiency syndrome (TDS) and the heart
Jackson
Eur Heart J 2010;31:1436-1437.
FULL TEXT  

Testosterone for 'late-onset hypogonadism' in men?
DTB 2010;48:69-72.
ABSTRACT | FULL TEXT  

Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
Bhasin et al.
J. Clin. Endocrinol. Metab. 2010;95:2536-2559.
ABSTRACT | FULL TEXT  

Certainly More Guidelines than Rules
McLachlan
J. Clin. Endocrinol. Metab. 2010;95:2610-2613.
FULL TEXT  

Rapid loss of appendicular skeletal muscle mass is associated with higher all-cause mortality in older men: the prospective MINOS study
Szulc et al.
Am J Clin Nutr 2010;91:1227-1236.
ABSTRACT | FULL TEXT  

Low circulating androgens and mortality risk in heart failure
Guder et al.
Heart 2010;96:504-509.
ABSTRACT | FULL TEXT  

Androgen Receptor-dependent Transactivation of Growth Arrest-specific Gene 6 Mediates Inhibitory Effects of Testosterone on Vascular Calcification
Son et al.
J. Biol. Chem. 2010;285:7537-7544.
ABSTRACT | FULL TEXT  

Associations of Total Testosterone, Sex Hormone-Binding Globulin, Calculated Free Testosterone, and Luteinizing Hormone with Prevalence of Abdominal Aortic Aneurysm in Older Men
Yeap et al.
J. Clin. Endocrinol. Metab. 2010;95:1123-1130.
ABSTRACT | FULL TEXT  

Sex Steroid Hormone Concentrations and Risk of Death in US Men
Menke et al.
Am J Epidemiol 2010;171:583-592.
ABSTRACT | FULL TEXT  

Salivary Sex Hormone Measurement in a National, Population-Based Study of Older Adults
Gavrilova and Lindau
J Gerontol B Psychol Sci Soc Sci 2009;64B:i94-i105.
ABSTRACT | FULL TEXT  

Review: Androgens, erectile dysfunction and cardiovascular risk in type 2 diabetes
Hackett
British Journal of Diabetes & Vascular Disease 2009;9:214-217.
ABSTRACT  

Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso Study
Vikan et al.
Eur J Endocrinol 2009;161:435-442.
ABSTRACT | FULL TEXT  

Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men
Mathur et al.
Eur J Endocrinol 2009;161:443-449.
ABSTRACT | FULL TEXT  

The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease
Traish et al.
J Androl 2009;30:477-494.
ABSTRACT | FULL TEXT  

Good Semen Quality and Life Expectancy: A Cohort Study of 43,277 Men
Jensen et al.
Am J Epidemiol 2009;170:559-565.
ABSTRACT | FULL TEXT  

Lower Testosterone Levels Predict Incident Stroke and Transient Ischemic Attack in Older Men
Yeap et al.
J. Clin. Endocrinol. Metab. 2009;94:2353-2359.
ABSTRACT | FULL TEXT  

Low Serum Testosterone and Estradiol Predict Mortality in Elderly Men
Tivesten et al.
J. Clin. Endocrinol. Metab. 2009;94:2482-2488.
ABSTRACT | FULL TEXT  

Testosterone therapy in men
Theodoraki and Bouloux
Menopause Int 2009;15:87-92.
ABSTRACT | FULL TEXT  

Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients
Carrero et al.
J. Am. Soc. Nephrol. 2009;20:613-620.
ABSTRACT | FULL TEXT  

The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Traish et al.
J Androl 2009;30:23-32.
ABSTRACT | FULL TEXT  

Testosterone deficiency--the male menopause?
Simon
InnovAiT 2008;1:625-630.
ABSTRACT | FULL TEXT  

Variation in Estrogen-Related Genes Associated with Cardiovascular Phenotypes and Circulating Estradiol, Testosterone, and Dehydroepiandrosterone Sulfate Levels
Peter et al.
J. Clin. Endocrinol. Metab. 2008;93:2779-2785.
ABSTRACT | FULL TEXT  

Low Serum Testosterone and Mortality in Older Men
Laughlin et al.
J. Clin. Endocrinol. Metab. 2008;93:68-75.
ABSTRACT | FULL TEXT  

Testosterone Making an Entry Into the Cardiometabolic World
Basaria and Dobs
Circulation 2007;116:2658-2661.
FULL TEXT  

Relationship Between Low Levels of Anabolic Hormones and 6-Year Mortality in Older Men: The Aging in the Chianti Area (InCHIANTI) Study
Maggio et al.
Arch Intern Med 2007;167:2249-2254.
ABSTRACT | FULL TEXT  

Androgen Receptor Gene CAG Repeat Length and Body Mass Index Modulate the Safety of Long-Term Intramuscular Testosterone Undecanoate Therapy in Hypogonadal Men
Zitzmann and Nieschlag
J. Clin. Endocrinol. Metab. 2007;92:3844-3853.
ABSTRACT | FULL TEXT  

Prevalence and Consequences of Androgen Deficiency in Young Male Cancer Survivors in a Controlled Cross-Sectional Study
Greenfield et al.
J. Clin. Endocrinol. Metab. 2007;92:3476-3482.
ABSTRACT | FULL TEXT  

Sex Steroids and All-Cause and Cause-Specific Mortality in Men
Araujo et al.
Arch Intern Med 2007;167:1252-1260.
ABSTRACT | FULL TEXT  

In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study
Yeap et al.
Eur J Endocrinol 2007;156:585-594.
ABSTRACT | FULL TEXT  

Medical Implications of the Male Biological Clock.
Lewis et al.
JAMA 2006;296:2369-2371.
FULL TEXT  

Endocrinology & Metabolism News, October 2006
J. Clin. Endocrinol. Metab. 2006;91:17a-17a.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.